Peptide Decoding
New?New to peptides?Start here →
Decoding

IGF-1 DES_Dosage, benefits & legal status

Also known as DES(1-3) IGF-1

Published July 22, 2026 · Updated October 4, 2026

A short-acting muscle-builder that works right where you inject it.

Muscle (localized)IGF-1 variantResearch onlyHigh-risk
Common vial size1 mg
Dose0.05 up to 0.15 mg per dose (start low, increase slowly)
FrequencyAround training
RouteUnder the skin or into muscle
StatusResearch only
CycledUsed around training rather than on a cycle

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is IGF-1 DES?

Plain language first. The technical label stays, but it never stands alone.

Overview

Injected into a specific muscle, it drives growth right there, then clears quickly.

The technical version

IGF-1 DES is a short, extra-potent version of insulin-like growth factor 1 that acts locally.

What it's used for

A short-acting muscle-builder that works right where you inject it, used to target a specific muscle.

02

How does IGF-1 DES work?

What it does in the body, and where.

IGF-1 DES is a shortened, more potent IGF-1 that acts where you put it and then disappears.

  1. 01
    It binds IGF-1 receptors at the injection site
    With the first three amino acids removed, it binds the receptor more strongly and the binding proteins less.
  2. 02
    The effect is local
    Which is the entire reason for using it rather than LR3: growth is meant to happen in the muscle you injected.
  3. 03
    It clears within minutes
    Short enough that systemic effects, including the blood-sugar drop, are smaller.
  4. 04
    No human evidence for the localised-growth claim
    The pharmacology is real. The training application is not studied.
Anatomical model of a standing human figure showing muscle and tendon tissue
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Muscle

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Growing a specific muscle at the injection siteResearch only

The published record

Research index

210

Papers and trials about IGF-1 DES

Searched: des(1-3)IGF-I, des(1-3)IGF-1, des-IGF-1, des(1-3) IGF-1, IGF-1 DES, des(1-3)-insulin-like growth factor.

91 papers tagged human · 59 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

Prohibited at all times, in and out of competition. S2.3 Growth factors and growth factor modulators: Insulin-like growth factor 1 (IGF-1, mecasermin) and its analogues. Non-Specified.Regulators
In animals148
In the lab76
Reviews7
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

IGF-1 DES vial rendering
Compound field notes

At a glance

Four things to know about IGF-1 DES

01

Evidence

Research only

02

Category

Muscle building

03

Common vial

1 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

0.05 up to 0.15 mg per dose (start low, increase slowly), around training. Used around training rather than on a cycle Community practice

Because it acts where it is injected and then clears, it is used per session rather than run continuously. No human study establishes a schedule.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No human or animal pharmacokinetic study has been published. IGF-1 DES is a shortened form of IGF-1 and its behavior cannot be read across from the full molecule.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced range: 50 up to 150 mcgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW10 / 100 units
What it costs

IGF-1 DES starts at $23.26 across 19 vendors, typically $28.00 – $92.50 per mg.

20 listings, last read Oct 24, 2026. Shipping and card fees are not included.

See all 20 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized IGF-1 DES keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

Mixing exception: reconstitute this one with a dilute acetic acid solution, not bacteriostatic water. Plain BAC water can degrade it, so follow the product's own mixing instructions.

Solubility, computed: 27% charged residues, 46% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.

Stop and get help

These are emergencies. Seek care.
  • Signs of very low blood sugar such as shaking, sweating, confusion, or fainting
  • New lumps or masses
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Low blood sugar
  • Injection-site reactions and localised swelling

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is IGF-1 DES approved?

And where the numbers on this page come from.

No. IGF-1 DES is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin or into muscle
  • Checked
    22 July 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

What regulators say

From official documents

Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.

You can compare this against the whole library, or read how to check a seller.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 210 records are indexed. Browse the records